NCT05182814

Brief Summary

To assess Collagen Drink on skin condition and sleep quality improvement

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 10, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

June 13, 2022

Status Verified

March 1, 2022

Enrollment Period

4 months

First QC Date

January 4, 2022

Last Update Submit

June 9, 2022

Conditions

Outcome Measures

Primary Outcomes (9)

  • The change of skin wrinkles

    VISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units

    Change from Baseline skin wrinkles at 8 weeks

  • The change of skin texture

    VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units

    Change from Baseline skin texture at 8 weeks

  • The change of skin collagen density

    DermaLab® Series SkinLab Combo was utilized to measure skin pores. Units: arbitrary units

    Change from Baseline skin collagen density at 8 weeks

  • The change of skin elasticity

    Cutometer® MPA580 was utilized to measure skin elasticity. Units: arbitrary units

    Change from Baseline skin elasticity at 8 weeks

  • The change of skin L* value

    Chroma Meter MM500 was utilized to measure skin L\* value. Units: arbitrary units, 0-100

    Change from Baseline L* value at 8 weeks

  • The change of sleep quality

    Self-assessment questionnaire was utilized to survey sleep quality.

    Change from Baseline sleep quality at 8 weeks

  • The change of AGEs of blood

    Venous blood was sampled to measure AGEs

    Change from Baseline AGEs at 8 weeks

  • The change of TIMP-1 of blood

    Venous blood was sampled to measure TIMP-1

    Change from Baseline TIMP-1 at 8 weeks

  • The change of desmosine of blood

    Venous blood was sampled to measure desmosine

    Change from Baseline desmosine at 8 weeks

Secondary Outcomes (5)

  • The change of skin melanin index

    Change from Baseline skin melanin index at 8 weeks

  • The change of skin pores

    Change from Baseline skin pores at 8 weeks

  • The change of skin a* value

    Change from Baseline skin a* value at 8 weeks

  • The change of skin hydration

    Change from Baseline skin hydration at 8 weeks

  • The change of transepidermal water loss

    Change from Baseline transepidermal water loss at 8 weeks

Study Arms (2)

Placebo drink

PLACEBO COMPARATOR
Dietary Supplement: Placebo drink

Collagen drink

EXPERIMENTAL
Dietary Supplement: Collagen Juice Drink

Interventions

Placebo drinkDIETARY_SUPPLEMENT

Blank

Placebo drink
Collagen Juice DrinkDIETARY_SUPPLEMENT

Testing product

Also known as: LISAVEI® Collagen Juice Drink
Collagen drink

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults aged above 20 years old

You may not qualify if:

  • Subject who is not willing to participate in this study.
  • Patients with diseases of the skin, liver, kidney.
  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
  • Female who is pregnant or nursing
  • Constant drug use
  • Received facial laser therapy, chemical peeling or UV overexposure (\>3 hours everyday) in the past 4 weeks.
  • Students taught by the PI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chia Nan University of Pharmacy & Science

Tainan, 71710, Taiwan

Location

MeSH Terms

Conditions

Skin DiseasesParasomnias

Condition Hierarchy (Ancestors)

Skin and Connective Tissue DiseasesSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2022

First Posted

January 10, 2022

Study Start

November 10, 2021

Primary Completion

February 28, 2022

Study Completion

April 30, 2022

Last Updated

June 13, 2022

Record last verified: 2022-03

Locations